Replies to post #104015 on Biotech Values

[DewDiligence]

your study-to-study comparisons [of Telaprevir vs Boceprevir] are very unscientific.

Of course they are.

You continue to post these comparisons like its gospel.

Like gospel? Where did you get that impression?

…what you are doing is not…allowed in the real world.

Huh? I’m an investor, not a sales rep. I can make any comparison I want that assists me in investment decision-making. On that score, I think it’s essential to grasp the material in #msg-54316658 in order to not be hoodwinked by MRK’s unconventional definition of null responder.